Metal-Mediated C-H Radiofluorination for Rapid Access to PET Imaging Agents
金属介导的 C-H 放射性氟化用于快速获得 PET 成像剂
基本信息
- 批准号:10369752
- 负责人:
- 金额:$ 8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:2-arachidonylglycerolAcidsAdoptionAgrochemicalsAmidinesAminesAntimalarialsBiotechnologyChemistryChloroquineClinicalClinical TrialsCopperDataDetectionDevelopmentDiagnosticDisciplineDiseaseDisease ProgressionDrug CostsDrug IndustryDrug TargetingElementsEnvironmentFinancial costFluoridesFluorineGoalsGrantHealthcare IndustryHumanHydrogen BondingImageImage EnhancementImaging TechniquesInstitutionInterdisciplinary StudyKnowledgeLabelLaboratoriesLibrariesLigandsManualsMediatingMedicineMentorsMetalsMethodologyMethodsMichiganMissionModelingMonitorNational Institute of Biomedical Imaging and BioengineeringOrganometallic ChemistryOxidesPeriodicityPharmaceutical PreparationsPharmacologic SubstancePharmacologyPhasePopulation AnalysisPositioning AttributePositron-Emission TomographyPreparationProceduresProcessProductionPropertyProtocols documentationQuinineRadioRadioactiveRadiochemistryRadioisotopesRadiolabeledRadiology SpecialtyRadiopharmaceuticalsReactionResearchResearch DesignResearch ProposalsRoleSaltsScanningSilverSilver CompoundsSodium ChlorideTracerTrainingTranslatingUniversitiesValidationVitamin B6analogbasebioactive scaffoldbioimagingcancer imagingcareercareer developmentclinical translationcostdesigndisease diagnosticdisorder preventiondrug developmentdrug discoveryexperienceexperimental studyimaging agentimaging modalityimaging studyimprovedinnovationinventionneuroimagingnovelnovel therapeuticsnuclear imagingoxidationpatient populationprotocol developmentquinolinescaffoldscreeningskillsstable isotopetranslational study
项目摘要
Project Summary/Abstract
Fluorine is an essential constituent of many commercial molecules, including (radio)pharmaceuticals,
agrochemicals, and functional materials. Fluorine-19 (stable isotope) is routinely introduced into aromatic
pharmaceuticals in order to modulate pharmacological properties. Many positron emission tomography aromatic
(PET) imaging agents are labeled with fluorine-18 (radioactive isotope) for studying and monitoring disease, as
well as evaluating drug-target engagements and enriching clinical trials. Considerable progress has been made
in the development of aromatic fluorine-18 imaging agents for these applications, although more robust
radiosyntheses are required to support and expedite tracer discovery and meet the increasing demand for
radiopharmaceuticals from the healthcare and pharmaceutical industries. The primary aim of this project is to
overcome challenges associated with radiofluorination through the invention of radiosynthetic methods that
support the design of aromatic PET imaging agents. Specifically, the central claim is that radiofluorinated organic
molecules can be accessed by designing silver- and copper-containing species competent in C-H
radiofluorination. Copper is an abundant and inexpensive element that has previously been shown to
(radio)fluorinate aromatic C-H bonds, albeit with a limited scope. Silver resides in the same periodic group as
copper and preliminary data suggests that it can induce C-H radiofluorination transformations. To achieve these
goals, the proposal is divided into three aims: Aim 1 is to use fluorine-18 labeled silver compounds for the
radiofluorination of organic molecules. Aim 2 is to utilize this method for the automated radiosynthesis of fluorine-
18 labeled bioactive molecules Aim 3 is to develop new copper-mediated C-H functionalization methodologies
for the direct, automated fluorine-18 labeling of aromatic bioactive molecules. Ultimately, enhancement of this
imaging modality as described in this grant is expected to fundamentally alter the current radiosynthetic paradigm
and expedite aromatic radiofluorination, providing new and rapid access to fluorine-18 labeled pharmaceuticals
used in PET. Importantly, developments in PET biotechnology are continually being used to fundamentally
improve the detection, treatment, and prevention of disease, consistent with the mission of NIBIB. This grant
builds on the ongoing multidisciplinary collaboration between Prof Peter J. H. Scott (Department of Radiology)
and Prof Melanie S. Sanford (Department of Chemistry), which focuses on the development of radiosynthetic
methods at the University of Michigan. The facilities and faulty/staff expertise offered in these laboratories
provide an outstanding research environment that will facilitate the candidate's acquisition of further skills
necessary for gaining an academic position at a US institution, consistent with his long-term career goal. In
particular, this project will provide new opportunities to merge radiochemistry and organometallic chemistry,
which will serve the candidate's career development toward a professorship in chemistry with a focus on C-H
radiolabeling for PET applications.
项目概要/摘要
氟是许多商业分子的重要组成部分,包括(放射性)药物、
农用化学品、功能材料。 Fluor-19(稳定同位素)通常被引入芳烃中
药物以调节药理特性。多正电子发射断层扫描芳香族
(PET) 显像剂用氟 18(放射性同位素)标记,用于研究和监测疾病,如
以及评估药物靶点参与和丰富临床试验。已经取得了长足的进步
为这些应用开发芳香族氟 18 显像剂,尽管更稳健
需要放射合成来支持和加速示踪剂发现并满足日益增长的需求
来自医疗保健和制药行业的放射性药物。该项目的主要目的是
通过发明放射合成方法克服与放射氟化相关的挑战
支持芳香族 PET 显像剂的设计。具体来说,核心主张是放射性氟化有机物
可以通过设计具有 C-H 能力的含银和铜物质来获得分子
放射性氟化。铜是一种丰富且廉价的元素,之前已被证明可以
(放射性)氟化芳香族 C-H 键,尽管范围有限。银与以下元素属于同一周期群:
铜和初步数据表明它可以诱导 C-H 放射性氟化转变。为了实现这些
目标,该提案分为三个目标: 目标 1 是使用氟 18 标记的银化合物
有机分子的放射性氟化。目标 2 是利用该方法进行氟的自动放射合成
18 个标记的生物活性分子目标 3 是开发新的铜介导的 C-H 功能化方法
用于芳香族生物活性分子的直接、自动化氟 18 标记。最终,加强这一点
本次资助中描述的成像方式预计将从根本上改变当前的放射合成范式
并加速芳香族放射性氟化,提供新的、快速的氟 18 标记药物的获取
用于PET。重要的是,PET 生物技术的发展不断被用于从根本上
改善疾病的检测、治疗和预防,这与 NIBIB 的使命是一致的。这笔补助金
建立在 Peter J. H. Scott 教授(放射科)之间持续进行的多学科合作的基础上
和 Melanie S. Sanford 教授(化学系),专注于放射合成的发展
密歇根大学的方法。这些实验室提供的设施和故障/人员专业知识
提供卓越的研究环境,促进候选人获得进一步的技能
在美国机构获得学术职位所必需的,这符合他的长期职业目标。在
特别是,该项目将为合并放射化学和有机金属化学提供新的机会,
这将为候选人的职业发展提供帮助,使其成为化学教授,重点是 C-H
PET 应用的放射性标记。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jay Samuel Wright其他文献
Jay Samuel Wright的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jay Samuel Wright', 18)}}的其他基金
Metal-Mediated C-H Radiofluorination for Rapid Access to PET Imaging Agents
金属介导的 C-H 放射性氟化用于快速获得 PET 成像剂
- 批准号:
10615600 - 财政年份:2022
- 资助金额:
$ 8万 - 项目类别:
相似国自然基金
采用“酸诱导”法合成金纳米团簇及其催化二氧化碳电化学还原研究
- 批准号:21905284
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
采用分子桥键化等策略构建高效稳定的α-螺旋型抗菌肽构效关系研究
- 批准号:81773564
- 批准年份:2017
- 资助金额:62.0 万元
- 项目类别:面上项目
采用连锁不平衡关联分析技术定位胡麻脂肪酸成分相关QTL
- 批准号:31760400
- 批准年份:2017
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
采用仿生神经再生环境组织工程技术实验治疗大鼠脊髓损伤研究
- 批准号:81271388
- 批准年份:2012
- 资助金额:70.0 万元
- 项目类别:面上项目
采用质谱法研究抗肿瘤新药藤黄酸对生物分子的共价修饰作用以及新靶点的发现
- 批准号:81072609
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Asymmetric Single-Chain MspA nanopores for electroosmotic stretching and sequencing proteins
用于电渗拉伸和蛋白质测序的不对称单链 MspA 纳米孔
- 批准号:
10646810 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Development and Production of Standardized Reference Diets for Zebrafish Research
斑马鱼研究标准化参考饲料的开发和生产
- 批准号:
10823702 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Vitamin D and Healthy Aging: Establishing the Sled Dog Sentinel for the Circumpolar North
维生素 D 与健康老龄化:为北极圈建立雪橇犬哨兵
- 批准号:
10649356 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Diversity Supplement for Angiogenic and anti-microbial supports for pulp regeneration
用于牙髓再生的血管生成和抗微生物支持的多样性补充剂
- 批准号:
10889680 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
乌干达宫颈癌预防游戏规则改变者的混合实施-有效性试验
- 批准号:
10718609 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别: